Approval · Notice of Compliance 32375 · 2023
CEFA-LAK: Notice of Compliance 32375
Issued December 19, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 32375
- Date
- December 19, 2023
- Company
- Boehringer Ingelheim Animal Health Canada Inc.Burlington, Ontario, Canada
- Product type
- Veterinary
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Change in the drug product test and specification, container closure system, and addition of sterile designation
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CEFA-LAK | 02173263 | Marketed |
Medicinal ingredients
- CEPHAPIRIN SODIUM 20 MG per ML